SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-167433
Filing Date
2017-05-11
Accepted
2017-05-11 17:07:57
Documents
10
Period of Report
2017-05-10
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d212383d8k.htm 8-K 22813
2 EX-1.1 d212383dex11.htm EX-1.1 157504
3 EX-5.1 d212383dex51.htm EX-5.1 12691
4 EX-10.1 d212383dex101.htm EX-10.1 42383
5 EX-99.1 d212383dex991.htm EX-99.1 8294
6 EX-99.2 d212383dex992.htm EX-99.2 8363
7 GRAPHIC g212383dsp042.jpg GRAPHIC 2001
8 GRAPHIC g212383g0511142550097.jpg GRAPHIC 5138
9 GRAPHIC g212383g0511235619642.jpg GRAPHIC 5138
10 GRAPHIC g212383g11j50.jpg GRAPHIC 3084
  Complete submission text file 0001193125-17-167433.txt   275053
Mailing Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127
Business Address 16745 WEST BERNARDO DRIVE Suite 200 San Diego CA 92127 (858) 376-2600
Conatus Pharmaceuticals Inc. (Filer) CIK: 0001383701 (see all company filings)

IRS No.: 203183915 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36003 | Film No.: 17835336
SIC: 2834 Pharmaceutical Preparations